Lansoprazole and Terminal insomnia - a phase IV clinical study of FDA data

Summary:

Terminal insomnia is reported as a side effect among people who take Lansoprazole (lansoprazole), especially for people who are male, 60+ old, also take Simponi, and have Ankylosing spondylitis.

The phase IV clinical study analyzes which people have Terminal insomnia when taking Lansoprazole. It is created by eHealthMe based on reports of 128,069 people who have side effects when taking Lansoprazole from the FDA, and is updated regularly.

What is Lansoprazole?

Lansoprazole has active ingredients of lansoprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 129,663 Lansoprazole users. Check the latest studies of Lansoprazole.

What is Terminal insomnia?

Terminal insomnia (a sleep disorder in which there is an inability to fall asleep or to stay asleep as long as desired) is found to be associated with 206 drugs and 345 conditions by eHealthMe. Check the latest studies of Terminal insomnia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 21, 2026

128,069 people reported to have side effects when taking Lansoprazole.
Among them, 41 people (0.03%) have Terminal insomnia.

Could Lansoprazole cause Terminal insomnia?

Among these 41 people:

What is the gender of people who have Terminal insomnia when taking Lansoprazole? *

female: 0.0 %
male: 100 %

What is the age of people who have Terminal insomnia when taking Lansoprazole? *

What are other drugs people take besides Lansoprazole? *

What are other side effects people have besides Terminal insomnia? *

Weakness: 40 people, 97.56%
Kidney Infection: 39 people, 95.12%
Itching: 39 people, 95.12%
Injection Site Warmth: 39 people, 95.12%
Injection Site Reaction: 39 people, 95.12%
Injection Site Mass: 39 people, 95.12%
Injection Site Erythema (redness at injection site): 39 people, 95.12%
Hypotension (abnormally low blood pressure): 39 people, 95.12%
Headache (pain in head): 39 people, 95.12%
Feeling Hot: 39 people, 95.12%

What are the existing conditions these people have? *

Ankylosing Spondylitis (type of arthritis affecting the spine): 37 people, 90.24%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 2.44%
Platelet Disorder: 1 person, 2.44%
High Blood Cholesterol: 1 person, 2.44%
Dyskinesia (abnormality or impairment of voluntary movement): 1 person, 2.44%

* Approximation only. Some reports may have incomplete information.

Do you take Lansoprazole and have Terminal insomnia?

- Check whether Terminal insomnia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lansoprazole:

Lansoprazole (129,663 reports)

Browse all side effects of Lansoprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Terminal insomnia:

Terminal insomnia (206 drugs)

Browse all the conditions that are associated with Terminal insomnia:

Terminal insomnia (345 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lansoprazole (the active ingredients of Lansoprazole) and Lansoprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.